SCHEMBL7656358

SCHEMBL7656358

O=C(NC(CO)(CO)CO)c1ccc(C(=O)NC(CO)(CO)CO)nc1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.49
KDM4E B2RXH2 2/20 0.49
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
P4HTM Q9NXG6 9/20 0.46
P4HA1 P13674 1/20 0.46
MIF P14174 1/20 0.46
GLA P06280 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
POLB P06746 1/20 0.42
LMNA P02545 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CNR2 P34972 1/20 0.41
AHR P35869 1/20 0.41
MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7652101 0.84 KMT2A (0.55) ALDH1A1KDM4ENPC1RAB9AP4HTM
SCHEMBL7107999 0.82 CNR2 (0.44) KDM4EGLAL3MBTL1KMT2ACNR2
SCHEMBL11253022 0.80 KDM4E (0.50) ALDH1A1KDM4ENPC1RAB9AGLA
SCHEMBL8824679 0.74 THRB (0.54) ALDH1A1KDM4ENPC1RAB9AP4HTM
SCHEMBL1020382 0.73 P4HTM (0.59) ALDH1A1KDM4ENPC1RAB9AP4HTM
SCHEMBL7105213 0.73 CNR2 (0.39) KDM4EGLAL3MBTL1POLBSMN1; SMN2
SCHEMBL9180143 0.73 ALDH1A1 (0.56) ALDH1A1KDM4ENPC1RAB9AP4HTM
SCHEMBL7660982 0.72 POLB (0.56) ALDH1A1KDM4ENPC1RAB9AMEN1
SCHEMBL19283447 0.72 KDM4E (0.54) ALDH1A1KDM4ENPC1RAB9AGLA
SCHEMBL7108736 0.72 CNR2 (0.38) KDM4EGLAL3MBTL1KMT2ACNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399613-B1 N,N'-BIS(2-HYDROXYETHYL)PYRAZINE-2,5- OR -2,6-DICARBOXAMIDE; DIABETES AVENTIS PHARMA S.A. (FR) 2002-06-04 US claimed
WO-2020184628-A1 LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT USING SAME 日産化学株式会社 2020-09-17 WO disclosed
US-6399613-B1 N,N'-BIS(2-HYDROXYETHYL)PYRAZINE-2,5- OR -2,6-DICARBOXAMIDE; DIABETES AVENTIS PHARMA S.A. (FR) 2002-06-04 US disclosed